Merdad Parsey, Chief Medical Officer: Gilead Sciences GILD Sell · Filed 24/11/29

Trade details

Type: Insider sale
Amount: $5,259,016.26
Shares · price: 57,294 sh · $91.79 a share
Held after: 187,718 sh
Stock: Gilead Sciences GILD
Person: Merdad ParseyChief Medical Officer
Trade date: 24/11/27
Filed: 24/11/29
Days to filing: 2 days

Sold 23.4% of holdings

Share of holding sold: 23.4%

Gilead Sciences trades, last 26 weeks

What else happened in Gilead Sciences around then

Filed or reported within 30 days of the trade day · 24/10/28~24/12/27

Merdad Parsey's recent trades

V. Parsey MerdadOfficer
Planned sale10b5-1 planGilead Sciences
Planned sale10b5-1 plan
Gilead Sciences
GILD
$2.5M
21,910 sh
$2.5M
Filed 25/03/03
Traded 25/03/03
V. Parsey MerdadOfficer
Planned sale10b5-1 planGilead Sciences
Planned sale10b5-1 plan
Gilead Sciences
GILD
$18.1M
184,683 sh
$18.1M
Filed 25/01/31
Traded 25/01/31
Merdad ParseyChief Medical Officer
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$8.1M
88,119 sh
$8.1M
Filed 24/11/29
Traded 24/11/27
Merdad ParseyChief Medical Officer
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$956.7K
10,399 sh
$956.7K
Filed 24/11/29
Traded 24/11/27
Merdad ParseyChief Medical Officer
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$477.4K
5,200 sh
$477.4K
Filed 24/11/29
Traded 24/11/27

Merdad Parsey, Chief Officer — sold $5.3M of Gilead Sciences GILD · 23.4% of holdings · 10b5-1 plan | Whalegun